CRB
Chad R. Baker Portfolio holdings
AUM
$538M
This Quarter Return
+2.52%
1 Year Return
+20.8%
3 Year Return
+87.18%
5 Year Return
+140.51%
10 Year Return
–
AUM
$511M
AUM Growth
+$511M
(+0.35%)
Cap. Flow
+$619K
Cap. Flow
% of AUM
0.12%
Top 10 Holdings %
Top 10 Hldgs %
46.76%
Holding
51
New
1
Increased
3
Reduced
11
Closed
1
Top Buys
| 1 |
Salesforce
CRM
|
$2.94M |
| 2 |
UL Solutions
ULS
|
$2.67M |
| 3 |
RELX
RELX
|
$2.53M |
| 4 |
Alcon
ALC
|
$27.6K |
Top Sells
| 1 |
Apple
AAPL
|
$5.01M |
| 2 |
Aptiv
APTV
|
$1.07M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$568K |
| 4 |
Pfizer
PFE
|
$318K |
| 5 |
CRISPR Therapeutics
CRSP
|
$239K |
Sector Composition
| 1 | Technology | 31.94% |
| 2 | Industrials | 19.07% |
| 3 | Healthcare | 15.81% |
| 4 | Consumer Discretionary | 13.29% |
| 5 | Communication Services | 10.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Alcon
ALC
$38.7B
| $7.63M | 1.49% |
89,850
+325
| +0.4% | +$27.6K |
|
27
TJX Companies
TJX
$155B
| $7.53M | 1.47% |
62,340
| – | – |
|
28
New York Times
NYT
$9.63B
| $7.46M | 1.46% |
143,325
| – | – |
|
29
Lowe's Companies
LOW
$145B
| $6.94M | 1.36% |
28,100
| – | – |
|
30
Stryker
SYK
$149B
| $6.88M | 1.35% |
19,095
| – | – |
|
31
Home Depot
HD
$404B
| $6.86M | 1.34% |
17,635
| – | – |
|
|
32
UL Solutions
ULS
$12.9B
| $5.6M | 1.1% |
112,300
+53,500
| +91% | +$2.67M |
|
|
33
RELX
RELX
$83B
| $5.11M | 1% |
112,450
+55,675
| +98% | +$2.53M |
|
34
Colgate-Palmolive
CL
$68.2B
| $4.65M | 0.91% |
51,200
| – | – |
|
35
RTX Corp
RTX
$212B
| $4.44M | 0.87% |
38,348
| – | – |
|
|
36
Alphabet (Google) Class C
GOOG
$2.56T
| $4.21M | 0.82% |
22,100
| – | – |
|
37
Zoetis
ZTS
$67.8B
| $4.04M | 0.79% |
24,818
| – | – |
|
38
Adobe
ADBE
$147B
| $4M | 0.78% |
9,000
| – | – |
|
39
Vertex Pharmaceuticals
VRTX
$103B
| $3.92M | 0.77% |
9,740
| – | – |
|
|
40
CRISPR Therapeutics
CRSP
$4.79B
| $3.67M | 0.72% |
93,205
-6,075
| -6% | -$239K |
|
41
CSX Corp
CSX
$60B
| $3.29M | 0.64% |
102,000
| – | – |
|
|
42
Salesforce
CRM
$242B
| $2.94M | 0.58% |
+8,790
| New | +$2.94M |
|
43
Merck
MRK
$214B
| $2.04M | 0.4% |
20,550
-1,150
| -5% | -$114K |
|
44
Exxon Mobil
XOM
$489B
| $1.76M | 0.35% |
16,400
| – | – |
|
45
Cigna
CI
$80.3B
| $1.61M | 0.32% |
5,841
| – | – |
|
46
NVIDIA
NVDA
$4.16T
| $1.33M | 0.26% |
9,870
-630
| -6% | -$84.6K |
|
47
McCormick & Company Non-Voting
MKC
$18.5B
| $1.19M | 0.23% |
15,625
| – | – |
|
48
Becton Dickinson
BDX
$53.9B
| $893K | 0.17% |
3,935
-450
| -10% | -$102K |
|
49
Novo Nordisk
NVO
$251B
| $444K | 0.09% |
5,160
-20
| -0.4% | -$1.72K |
|
|
50
Pfizer
PFE
$142B
| $332K | 0.06% |
12,500
-12,000
| -49% | -$318K |
|